Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
02/2012
02/22/2012CN102058708B 黄连解毒散固体分散体及其制备方法 Huanglianjiedu bulk solid dispersion and its preparation method
02/22/2012CN101991546B 一种甲磺酸左氧氟沙星冻干粉针剂及其制备方法 Levofloxacin Mesylate a freeze-dried powder and its preparation method
02/22/2012CN101966228B 一种厚朴生物碱的用途 One kind of Magnolia officinalis alkaloid use
02/22/2012CN101940555B 一种注射用阿奇霉素冻干粉针剂的制备方法 An injectable preparation of freeze-dried powder of azithromycin
02/22/2012CN101904825B 泛昔洛韦分散片及其制备方法 Famciclovir tablet and its preparation method
02/22/2012CN101897672B 一种注射用阿昔洛韦冻干制剂的制备方法 Method for preparing an injectable lyophilized formulation of acyclovir
02/22/2012CN101890015B 一种哌拉西林钠他唑巴坦钠药物组合物脂质体注射剂 One kind of piperacillin sodium and tazobactam sodium pharmaceutical compositions liposomes injection
02/22/2012CN101856333B 头孢孟多酯钠冻干粉针制剂及其制备方法 Cefamandole ester sodium freeze-dried powder and its preparation method
02/22/2012CN101837072B 一种治疗肝炎的药物制剂的质量检测方法 A method of detecting the quality of a pharmaceutical formulation for treating hepatitis
02/22/2012CN101822640B 一种磺苄西林钠脂质体注射剂 One kind of methyl benzyl amoxicillin sodium liposome injection
02/22/2012CN101817834B 一类吡唑的衍生物、其制备方法和用途 A class of pyrazole derivatives, their preparation and use
02/22/2012CN101805385B 从羽芒菊中分离纯化的黄酮类化合物及其制备方法 Flavonoids isolated from purified Ju Yu Mang and its preparation method
02/22/2012CN101805285B 含烟酸姜黄素酯衍生物及其制造方法和用途 Nicotinic acid ester derivatives containing curcumin and its manufacturing method and use thereof
02/22/2012CN101804015B 一种含脱氢香薷酮结构的组合物及其应用 Containing composition and its application dehydrogenation Elsholtzia ketone structure
02/22/2012CN101780274B 猪链球菌病、多杀性巴氏杆菌病灭活疫苗及其制备方法 Streptococcus suis, Pasteurella multocida disease vaccine and its preparation method
02/22/2012CN101759651B 4,5-二芳基嘧啶硫脲化合物和药物用途 Pyrimidine-4,5-diaryl thiourea compound and pharmaceutical use
02/22/2012CN101757450B 一种治疗骨病的膏药 A method of treating bone disease plaster
02/22/2012CN101723926B 一种异黄酮衍生物及其制备方法和用途 An isoflavone derivatives and their preparation and use
02/22/2012CN101721450B 一种用于治疗腹膜炎的苍耳根氯仿提取物的应用 An application for the treatment of peritonitis chloroform extract of the root cocklebur
02/22/2012CN101716237B 一种治疗由轮状病毒所致的婴幼儿腹泻的中药组合物 A treatment caused by rotavirus diarrhea in infants and young children herbal composition
02/22/2012CN101559099B 治疗风寒感冒的中药组合物及其制备方法 Cure cold medicine composition and its preparation method
02/22/2012CN101347512B 一种博落回注射液及其制备方法 One kind cordata injection and its preparation method
02/22/2012CN101306121B 一种治疗急性结膜炎的熏洗药物 A method of treating acute conjunctivitis drug fumigation
02/22/2012CN101300027B 分泌性IgA和IgG抗体诱导剂 Secretory IgA and IgG antibody-inducing agent
02/22/2012CN101027084B 用于调节免疫的突变型hiv nef Mutant hiv nef for regulating immunity
02/22/2012CN101002801B 一种增强免疫力的保健食品的制备方法 A method of preparing a health food to enhance immunity
02/21/2012US8119691 Method for treating airway hyper-responsiveness with lipoxin analogs
02/21/2012US8119687 Derivatives of dioxan-2-alkyl carbamates, preparation thereof and application thereof in therapeutics
02/21/2012US8119678 Compounds, compositions and methods
02/21/2012US8119665 Aryl imidazoles and related compounds as C5a receptor modulators
02/21/2012US8119631 Inhibitors of interleukin-1β converting enzyme
02/21/2012US8119630 Benzodiazepine derivatives and pharmaceutical compositions containing them
02/21/2012US8119628 Pyrrolidine fused indolobenzadiazepine HCV NS5B inhibitors
02/21/2012US8119608 Specific inhibition of expression of target gene in mammals using short double stranded RNA; dsRNA less than 49 nucleotides in length, has nucleotide sequence complementary to part of target gene; treating cancer, Alzheimer's disease
02/21/2012US8119168 Topical antidandruff agents comprising mixtures of group IIB compounds such as zinc pyrithione, zinc oxide or calamine
02/21/2012US8119156 Dual action, inhaled formulations providing both an immediate and sustained release profile
02/21/2012CA2682254C 1,3-oxathiolane nucleoside analogues
02/21/2012CA2675025C Inhibitor of herpesvirus infection, method for inhibition of herpesvirus infection, and use thereof
02/21/2012CA2656124C Use of bacterial polysaccharides for biofilm inhibition
02/21/2012CA2524726C Heterocyclyl-substituted dihydroquinazolines and use thereof as an antiviral agent
02/21/2012CA2488372C Pyridazine derivatives which are phosphodiasterase iv inhibitors
02/21/2012CA2451981C 2,4,5-trisubstituted thiazolyl derivatives and their antiinflammatory activity
02/21/2012CA2444031C 3,4-di-substituted cyclobutene-1,2-diones as cxc-chemokine receptor ligands
02/21/2012CA2418962C Anti-dual integrin antibodies, compositions, methods and uses
02/21/2012CA2412460C Human monoclonal antibody against hepatitis c virus e2 glycoprotein
02/21/2012CA2394716C Hydrolytically degradable carbamate derivatives of poly(ethylene glycol)
02/21/2012CA2389080C Mistletoe lectins as mucosal adjuvants
02/21/2012CA2373300C Compositions and methods for generating an immune response utilizing alphavirus-based vector systems
02/21/2012CA2349760C Bovine cells expressing adeno virus essential functions for propagation of recombinant adenoviral vectors
02/16/2012WO2012021786A2 Anti-hemagglutinin antibody compositions and methods of use thereof
02/16/2012WO2012021735A2 Pharmaceutical products from gungal strains
02/16/2012WO2012021647A2 Modulators of nod1 and nod2 signaling, methods of identifying modulators of nod1 and nod2 signaling, and uses thereof
02/16/2012WO2012021591A1 Hepatitis c virus inhibitors
02/16/2012WO2012021578A1 Use of angiotensin- ii (1-7) in cell trans planation and as an agent for preventing/treating norovirus infection
02/16/2012WO2012021514A2 System and method for reverting antibiotic tolerance of bacterial persister cells
02/16/2012WO2012021455A1 Cyclic boronic acid ester derivatives and therapeutic uses thereof
02/16/2012WO2012021409A2 Anthraquinone Analogs
02/16/2012WO2012021141A1 Antisense antiviral compounds and methods for treating a filovirus infection
02/16/2012WO2012020836A1 Therapeutic agent for hepatitis c containing rrm2 antagonist as active ingredient
02/16/2012WO2012020790A1 Anti-infective agent
02/16/2012WO2012020785A1 Medicinal agent for prevention and/or treatment of hepatocellular carcinoma
02/16/2012WO2012020757A1 Production method for cell populations
02/16/2012WO2012020370A1 Galvinoxyl derivative for use thereof against lipoprotein-enveloped viruses, in particular herpesviruses
02/16/2012WO2012020037A1 Heterocyclic antiviral compounds
02/16/2012WO2012020036A1 Hepatitis c virus inhibitors
02/16/2012WO2012020021A1 Glycyrrhetinic acid amine analogues for use in the treatment of inflammation, infectious diseases, cancer, autoimmune diseases, skin diseases, bone diseases and metabolic diseases
02/16/2012WO2012019991A1 Methods and pharmaceutical compositions for the treatment of hiv-1 infections
02/16/2012WO2012019354A1 Method for reducing dna impurities in viral compositions
02/16/2012WO2011163610A3 Antimicrobial agents
02/16/2012WO2011133707A3 Anti-viral compounds
02/16/2012WO2011109104A3 Molecular clone of hiv-1
02/16/2012WO2011106105A9 Inhibitors for antiviral use
02/16/2012US20120041072 Antiviral agent
02/16/2012US20120041045 Use of pharmaceutical compositions containing mesembrenone
02/16/2012US20120041032 Metalloprotein inhibitors
02/16/2012US20120041030 Pyridine thio derivative, and pharmaceutical composition which contains same and has anti-helicobacter pylori action
02/16/2012US20120041019 Protease inhibitors
02/16/2012US20120040993 Neuroprotective multifunctional compounds and pharmaceutical compositions comprising them
02/16/2012US20120040989 2-hydroxyethyl-1h-quinolin-2-one derivatives and their azaisosteric analogues with antibacterial activity
02/16/2012US20120040984 Thiadiazole and oxadiazole derivatives, preparation thereof and therapeutic use thereof
02/16/2012US20120040983 Phthalazine Compounds as P38 Map Kinase Modulators and Methods of Use Thereof
02/16/2012US20120040977 Inhibitors of hcv ns5a
02/16/2012US20120040974 Mif modulators
02/16/2012US20120040966 Anti-viral compounds, treatment, and assay
02/16/2012US20120040962 Fused ring inhibitors of hepatitis c
02/16/2012US20120040961 Pyrimido-diazepinone kinase scaffold compounds and methods of treating disorders
02/16/2012US20120040959 8-methoxy-9h-isothiazolo[5,4-b]quinoline-3,4-diones and related compounds as anti-infective agents
02/16/2012US20120040957 Novel Bicyclic Antibiotics
02/16/2012US20120040951 Heteroaryl compounds useful as raf kinase inhibitors
02/16/2012US20120040946 Medicinal fusidic acid cream made using sodium fusidate and incorporating a biopolymer and a process to make it
02/16/2012US20120040933 9-(piperazinylalkyl) carbazoles as bax-modulators
02/16/2012US20120040932 Cyclic boronic acid ester derivatives and therapeutic uses thereof
02/16/2012US20120040927 Medicinal antifungal and steroid cream incorporating a biopolymer and a process to make it.
02/16/2012US20120040924 Purine nucleoside monophosphate prodrugs for treatment of cancer and viral infections
02/16/2012US20120040922 Antibiotic macrocycle compounds and methods of manufacture and use thereof
02/16/2012US20120040918 Peptide nucleic acid derivatives with good cell penetration and strong affinity for nucleic acid
02/16/2012US20120040897 Novel derivatives of acyl cyanopyrrolidines
02/16/2012US20120040891 Hiv fusion inhibitor peptides with improved biological properties
02/16/2012US20120040890 Inhibitor of the uracil-dna glycosylase enzyme and uses thereof
02/16/2012US20120040889 Peptidomimetic macrocycles
1 ... 320 321 322 323 324 325 326 327 328 329 330 331 332 333 334 335 336 337 338 339 340 ... 1798